Cirrhotic cardiomyopathy is a critical factor that causes morbidity and mortality in crucial
conditions such as liver transplantation. In animal model, the common pathophysiologic …

Background: Cirrhotic cardiomyopathy is a well-recognized cardiac dysfunction in cirrhotic
patients. Studies have confirmed the protective effects of silymarin in different types of …

Cirrhotic patients often suffer from cirrhotic cardiomyopathy (CCM). Previous animal models
of CCM were inconsistent concerning the time and mechanism of injury; thus, the temporal …

Objective (s): An increase in nitric oxide (NO) production has been reported in cirrhotic
cardiomyopathy and, portal hypertension. Since minocycline has been shown to inhibit NO …

Despite all previous studies relating to the mechanism of cirrhotic cardiomyopathy (CCM),
the role of cirrhosis on Ischemic Preconditioning (IPC) has not yet been explored. The …

Background/Aims: Attenuated cardiac function has been reported in cirrhosis as well as in
jaundice, but the mechanisms remain unclear. This study aimed to explore the differential …

Acute myocardial infarction (AMI) is an instant death of cardiomyocytes that ends in a large
mortality worldwide. Thus, there is a great interest to come up with novel protective …

Objectives This study was designed to explore the effect and mechanism of matrine, an
active component of Chinese traditional medicine, on isoproterenol-induced acute …

Background: There is no effective medication for treatment or prevention of hepatic ischemia-
reperfusion (HIR) injury caused by liver transplantation and hepatectomy. This study aimed …

Cirrhosis has been related with hyperdynamic circulation, manifesting as increased cardiac
output and decreased systemic vascular resistance. In the present study we examined the …